These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31996674)

  • 1. Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau.
    Ferrari L; Stucchi R; Konstantoulea K; van de Kamp G; Kos R; Geerts WJC; van Bezouwen LS; Förster FG; Altelaar M; Hoogenraad CC; Rüdiger SGD
    Nat Commun; 2020 Jan; 11(1):571. PubMed ID: 31996674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.
    Baughman HER; Clouser AF; Klevit RE; Nath A
    J Biol Chem; 2018 Feb; 293(8):2687-2700. PubMed ID: 29298892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp90 activator Aha1 drives production of pathological tau aggregates.
    Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
    Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
    J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90-Tau complex reveals molecular basis for specificity in chaperone action.
    Karagöz GE; Duarte AM; Akoury E; Ippel H; Biernat J; Morán Luengo T; Radli M; Didenko T; Nordhues BA; Veprintsev DB; Dickey CA; Mandelkow E; Zweckstetter M; Boelens R; Madl T; Rüdiger SG
    Cell; 2014 Feb; 156(5):963-74. PubMed ID: 24581495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species.
    Nachman E; Wentink AS; Madiona K; Bousset L; Katsinelos T; Allinson K; Kampinga H; McEwan WA; Jahn TR; Melki R; Mogk A; Bukau B; Nussbaum-Krammer C
    J Biol Chem; 2020 Jul; 295(28):9676-9690. PubMed ID: 32467226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids.
    KrishnaKumar VG; Paul A; Gazit E; Segal D
    Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.
    Rojas AV; Maisuradze GG; Scheraga HA
    J Phys Chem B; 2018 Jul; 122(28):7049-7056. PubMed ID: 29940109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.
    Dregni AJ; Mandala VS; Wu H; Elkins MR; Wang HK; Hung I; DeGrado WF; Hong M
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16357-16366. PubMed ID: 31358628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of Hsp90-induced oligomerizaton of Tau.
    Weickert S; Wawrzyniuk M; John LH; Rüdiger SGD; Drescher M
    Sci Adv; 2020 Mar; 6(11):eaax6999. PubMed ID: 32201713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
    Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
    Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP.
    Arya S; Claud SL; Cantrell KL; Bowers MT
    ACS Chem Neurosci; 2019 Nov; 10(11):4757-4765. PubMed ID: 31642657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical Studies of Amyloid-Binding Fluorophores to Tau AD Core Fibrils Formed without Cofactors.
    Freitas DP; Saavedra J; Cardoso I; Gomes CM
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA
    PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milligram-scale assembly and NMR fingerprint of tau fibrils adopting the Alzheimer's disease fold.
    Duan P; El Mammeri N; Hong M
    J Biol Chem; 2024 Jun; 300(6):107326. PubMed ID: 38679331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
    Gorantla NV; Chinnathambi S
    J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.